The DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.
Gut Microbiome in Progressive Multiple Sclerosis
Open accessAbstract
Objective: This study was undertaken to investigate the gut microbiome in progressive multiple sclerosis (MS) and how it relates to clinical disease. Methods: We sequenced the microbiota from healthy controls and relapsing–remitting MS (RRMS) and progressive MS patients and correlated the levels of bacteria with clinical features of disease, including Expanded Disability Status Scale (EDSS), quality of life, and brain magnetic resonance imaging lesions/atrophy. We colonized mice with MS‐derived Akkermansia and induced experimental autoimmune encephalomyelitis (EAE). Results: Microbiota β‐diversity differed between MS patients and controls but did not differ between RRMS and progressive MS or differ based on disease‐modifying therapies. Disease status had the greatest effect on the microbiome β‐diversity, followed by body mass index, race, and sex. In both progressive MS and RRMS, we found increased Clostridium bolteae,Ruthenibacterium lactatiformans, and Akkermansia and decreased Blautia wexlerae,Dorea formicigenerans, and Erysipelotrichaceae CCMM. Unique to progressive MS, we found elevated Enterobacteriaceae and Clostridium g24 FCEY and decreased Blautia and Agathobaculum. Several Clostridium species were associated with higher EDSS and fatigue scores. Contrary to the view that elevated Akkermansia in MS has a detrimental role, we found that Akkermansia was linked to lower disability, suggesting a beneficial role. Consistent with this, we found that Akkermansia isolated from MS patients ameliorated EAE, which was linked to a reduction in RORγt+ and IL‐17–producing γδ T cells. Interpretation: Whereas some microbiota alterations are shared in relapsing and progressive MS, we identified unique bacteria associated with progressive MS and clinical measures of disease. Furthermore, elevated Akkermansia in MS may be a compensatory beneficial response in the MS microbiome. ANN NEUROL 2021;89:1195–1211
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Metagenomic biomarker discovery and explanation
Segata, N., Izard, J., Waldron, L., Gevers, D., Miropolsky, L., Garrett, W. S., & Huttenhower, C. (2011) · Genome Biology · doi:10.1186/gb-2011-12-6-r60 · Cited by 16,192
Yoon, S.-H., Ha, S.-M., Kwon, S., Lim, J., Kim, Y., Seo, H., & Chun, J. (2017) · International Journal of Systematic and Evolutionary Microbiology · doi:10.1099/ijsem.0.001755 · Cited by 7,702
Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors
Routy, B., Le Chatelier, E., Derosa, L., Duong, C. P. M., Alou, M. T., Daillère, R., Fluckiger, A., Messaoudene, M., Rauber, C., Roberti, M. P., et al. (2018) · Science · doi:10.1126/science.aan3706 · Cited by 5,671
Bravo, J. A., Forsythe, P., Chew, M. V., Escaravage, E., Savignac, H. M., Dinan, T. G., Bienenstock, J., & Cryan, J. F. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102999108 · Cited by 3,888 · cited 1×
“clear, but it may be related to the microbial production of neurotransmitters.(78,79) Although there is debate on whether bacterial neurotransmitters cross the blood–brain barrier, it has been shown that administering γ-aminobutyric acid (GABA)-producing Lactobacillus reduces anxiety and depression in animal models,(7…”
BackgroundDysfunction of the intestinal microbiome in inflammatory bowel disease and treatment
Morgan, X. C., Tickle, T. L., Sokol, H., Gevers, D., Devaney, K. L., Ward, D. V., Reyes, J. A., Shah, S. A., LeLeiko, N., Snapper, S. B., et al. (2012) · Genome Biology · doi:10.1186/gb-2012-13-9-r79 · Cited by 2,713
Plovier, H., Everard, A., Druart, C., Depommier, C., Van Hul, M., Geurts, L., Chilloux, J., Ottman, N., Duparc, T., Lichtenstein, L., et al. (2017) · Nature Medicine · doi:10.1038/nm.4236 · Cited by 2,204
Louis, P., & Flint, H. J. (2009) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2009.01514.x · Cited by 2,179
Rothhammer, V., Mascanfroni, I. D., Bunse, L., Takenaka, M. C., Kenison, J. E., Mayo, L., Chao, C.-C., Patel, B., Yan, R., Blain, M., et al. (2016) · Nature Medicine · doi:10.1038/nm.4106 · Cited by 1,559
Blautia —a new functional genus with potential probiotic properties?
Liu, X., Mao, B., Gu, J., Wu, J., Cui, S., Wang, G., Zhao, J., Zhang, H., & Chen, W. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1875796 · Cited by 1,381
Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis
Lee, Y. K., Menezes, J. S., Umesaki, Y., & Mazmanian, S. K. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000082107 · Cited by 1,323
Alterations of the human gut microbiome in multiple sclerosis
Jangi, S., Gandhi, R., Cox, L. M., Li, N., von Glehn, F., Yan, R., Patel, B., Mazzola, M. A., Liu, S., Glanz, B. L., et al. (2016) · Nature Communications · doi:10.1038/ncomms12015 · Cited by 1,307
Self-citationCommensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination
Berer, K., Mues, M., Koutrolos, M., Rasbi, Z. A., Boziki, M., Johner, C., Wekerle, H., & Krishnamoorthy, G. (2011) · Nature · doi:10.1038/nature10554 · Cited by 1,251
GABA-modulating bacteria of the human gut microbiota
Strandwitz, P., Kim, K. H., Terekhova, D., Liu, J. K., Sharma, A., Levering, J., McDonald, D., Dietrich, D., Ramadhar, T. R., Lekbua, A., et al. (2018) · Nature Microbiology · doi:10.1038/s41564-018-0307-3 · Cited by 1,170 · cited 2×
“clear, but it may be related to the microbial production of neurotransmitters.(78,79) Although there is debate on whether bacterial neurotransmitters cross the blood–brain barrier, it has been shown that administering γ-aminobutyric acid (GABA)-producing Lactobacillus reduces anxiety and depression in animal models,(7…”
BackgroundTh17 cell induction by adhesion of microbes to intestinal epithelial cells
Atarashi, K., Tanoue, T., Ando, M., Kamada, N., Nagano, Y., Narushima, S., Suda, W., Imaoka, A., Setoyama, H., Nagamori, T., et al. (2015) · Cell · doi:10.1016/j.cell.2015.08.058 · Cited by 1,071 · cited 1×
“C bolteae was originally isolated from an autistic child and may induce Th17 cells by direct attachment to the mucosa.(35) It has been shown that gut microorganisms may act together via molecular mimicry and induction of Th17 cells to worsen spinal cord inflammation in the EAE model,(8) and the bacteria that we identi…”
BackgroundNext-Generation Beneficial Microbes: The Case of Akkermansia muciniphila
Cani, P. D., & de Vos, W. M. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01765 · Cited by 1,058
The Gut Microbiota Mediates the Anti-Seizure Effects of the Ketogenic Diet
Olson, C. A., Vuong, H. E., Yano, J. M., Liang, Q. Y., Nusbaum, D. J., & Hsiao, E. Y. (2018) · Cell · doi:10.1016/j.cell.2018.04.027 · Cited by 1,057
Cekanaviciute, E., Yoo, B. B., Runia, T. F., Debelius, J. W., Singh, S., Nelson, C. A., Kanner, R., Bencosme, Y., Lee, Y. K., Hauser, S. L., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1711235114 · Cited by 1,036
Multiple Sclerosis: Mechanisms and Immunotherapy
Baecher-Allan, C., Kaskow, B. J., & Weiner, H. L. (2018) · Neuron · doi:10.1016/j.neuron.2018.01.021 · Cited by 938
Self-citationMultiple sclerosis patients have a distinct gut microbiota compared to healthy controls
Chen, J., Chia, N., Kalari, K. R., Yao, J. Z., Novotna, M., Paz Soldan, M. M., Luckey, D. H., Marietta, E. V., Jeraldo, P. R., Chen, X., et al. (2016) · Scientific Reports · doi:10.1038/srep28484 · Cited by 933
Berer, K., Gerdes, L. A., Cekanaviciute, E., Jia, X., Xiao, L., Xia, Z., Liu, C., Klotz, L., Stauffer, U., Baranzini, S. E., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1711233114 · Cited by 933
Miyake, S., Kim, S., Suda, W., Oshima, K., Nakamura, M., Matsuoka, T., Chihara, N., Tomita, A., Sato, W., Kim, S.-W., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0137429 · Cited by 809
The host shapes the gut microbiota via fecal microRNA
Liu, S., da Cunha, A. P., Rezende, R. M., Cialic, R., Wei, Z., Bry, L., Comstock, L. E., Gandhi, R., & Weiner, H. L. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2015.12.005 · Cited by 808
Self-citationNeuro-QOL: Brief measures of health-related quality of life for clinical research in neurology
Cella, D., Lai, J.-S., Nowinski, C. J., Victorson, D., Peterman, A., Miller, D., Bethoux, F., Heinemann, A., Rubin, S., Cavazos, J. E., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e318258f744 · Cited by 785
Potential roles of gut microbiome and metabolites in modulating ALS in mice
Blacher, E., Bashiardes, S., Shapiro, H., Rothschild, D., Mor, U., Dori-Bachash, M., Kleimeyer, C., Moresi, C., Harnik, Y., Zur, M., et al. (2019) · Nature · doi:10.1038/s41586-019-1443-5 · Cited by 700
Regulation of prefrontal cortex myelination by the microbiota
Hoban, A. E., Stilling, R. M., Ryan, F. J., Shanahan, F., Dinan, T. G., Claesson, M. J., Clarke, G., & Cryan, J. F. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.42 · Cited by 635
Role of Gut Commensal Microflora in the Development of Experimental Autoimmune Encephalomyelitis
Ochoa-Repáraz, J., Mielcarz, D. W., Ditrio, L. E., Burroughs, A. R., Foureau, D. M., Haque-Begum, S., & Kasper, L. H. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900747 · Cited by 590
Sex and gender issues in multiple sclerosis
Harbo, H. F., Gold, R., & Tintoré, M. (2013) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285613488434 · Cited by 529
Ochoa-Repáraz, J., Mielcarz, D. W., Wang, Y., Begum-Haque, S., Dasgupta, S., Kasper, D. L., & Kasper, L. H. (2010) · Mucosal Immunology · doi:10.1038/mi.2010.29 · Cited by 507
Polarization of the Effects of Autoimmune and Neurodegenerative Risk Alleles in Leukocytes
Raj, T., Rothamel, K., Mostafavi, S., Ye, C., Lee, M. N., Replogle, J. M., Feng, T., Lee, M., Asinovski, N., Frohlich, I., et al. (2014) · Science · doi:10.1126/science.1249547 · Cited by 506
Möhle, L., Mattei, D., Heimesaat, M. M., Bereswill, S., Fischer, A., Alutis, M., French, T., Hambardzumyan, D., Matzinger, P., Dunay, I. R., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.04.074 · Cited by 470
Gut microbiota in multiple sclerosis: possible influence of immunomodulators
Cantarel, B. L., Waubant, E., Chehoud, C., Kuczynski, J., DeSantis, T. Z., Warrington, J., Venkatesan, A., Fraser, C. M., & Mowry, E. M. (2015) · Journal of Investigative Medicine · doi:10.1097/jim.0000000000000192 · Cited by 409
Zhai, R., Xue, X., Zhang, L., Yang, X., Zhao, L., & Zhang, C. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00239 · Cited by 368
Gray matter involvement in multiple sclerosis
Pirko, I., Lucchinetti, C. F., Sriram, S., & Bakshi, R. (2007) · Neurology · doi:10.1212/01.wnl.0000250267.85698.7a · Cited by 349
Self-citationMRI in multiple sclerosis: current status and future prospects
Bakshi, R., Thompson, A. J., Rocca, M. A., Pelletier, D., Dousset, V., Barkhof, F., Inglese, M., Guttmann, C. R., Horsfield, M. A., & Filippi, M. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70137-6 · Cited by 348
Self-citationGut microbiota in early pediatric multiple sclerosis: a case−control study
Tremlett, H., Fadrosh, D. W., Faruqi, A. A., Zhu, F., Hart, J., Roalstad, S., Graves, J., Lynch, S., Waubant, E., & the US Network of Pediatric MS Centers (2016) · European Journal of Neurology · doi:10.1111/ene.13026 · Cited by 347
Cosorich, I., Dalla-Costa, G., Sorini, C., Ferrarese, R., Messina, M. J., Dolpady, J., Radice, E., Mariani, A., Testoni, P. A., Canducci, F., et al. (2017) · Science Advances · doi:10.1126/sciadv.1700492 · Cited by 338
Benítez-Páez, A., Gómez del Pugar, E. M., López-Almela, I., Moya-Pérez, Á., Codoñer-Franch, P., & Sanz, Y. (2020) · mSystems · doi:10.1128/msystems.00857-19 · Cited by 337
Gut microorganisms act together to exacerbate inflammation in spinal cords
Miyauchi, E., Kim, S.-W., Suda, W., Kawasumi, M., Onawa, S., Taguchi-Atarashi, N., Morita, H., Taylor, T. D., Hattori, M., & Ohno, H. (2020) · Nature · doi:10.1038/s41586-020-2634-9 · Cited by 268
Human Gut-Derived Commensal Bacteria Suppress CNS Inflammatory and Demyelinating Disease
Mangalam, A., Shahi, S. K., Luckey, D., Karau, M., Marietta, E., Luo, N., Choung, R. S., Ju, J., Sompallae, R., Gibson-Corley, K., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.07.031 · Cited by 266
NKT Cell-Dependent Amelioration of a Mouse Model of Multiple Sclerosis by Altering Gut Flora
Yokote, H., Miyake, S., Croxford, J. L., Oki, S., Mizusawa, H., & Yamamura, T. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.080622 · Cited by 264
A probiotic modulates the microbiome and immunity in multiple sclerosis
Tankou, S. K., Regev, K., Healy, B. C., Tjon, E., Laghi, L., Cox, L. M., Kivisäkk, P., Pierre, I. V., Hrishikesh, L., Gandhi, R., et al. (2018) · Annals of Neurology · doi:10.1002/ana.25244 · Cited by 264
Self-citationAdjusting for age improves identification of gut microbiome alterations in multiple diseases
Ghosh, T. S., Das, M., Jeffery, I. B., & O'Toole, P. W. (2020) · eLife · doi:10.7554/elife.50240 · Cited by 233 · cited 1×
“The microbiome composition in adults is relatively stable and similar between young adults (20–40 years of age) and middleaged (40–60 years) adults, but can differ in adults older than 60 years.(77) To address this, we adjusted microbiota correlations with EDSS, MRI, and quality of life for age.”
BackgroundDuan, J., Chung, H., Troy, E., & Kasper, D. L. (2010) · Cell Host & Microbe · doi:10.1016/j.chom.2010.01.005 · Cited by 224
The Gut Microbiota Mediates the Anti-Seizure Effects of the Ketogenic Diet
Olson, C. A., Vuong, H. E., Yano, J. M., Liang, Q. Y., Nusbaum, D. J., & Hsiao, E. Y. (2018) · Cell · doi:10.1016/j.cell.2018.06.051 · Cited by 224
Microbiota Signaling Pathways that Influence Neurologic Disease
Cox, L. M., & Weiner, H. L. (2018) · Neurotherapeutics · doi:10.1007/s13311-017-0598-8 · Cited by 207
Self-citationKim, M., Galan, C., Hill, A. A., Wu, W.-J., Fehlner-Peach, H., Song, H. W., Schady, D., Bettini, M. L., Simpson, K. W., Longman, R. S., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.05.009 · Cited by 202
Liu, S., Rezende, R. M., Moreira, T. G., Tankou, S. K., Cox, L. M., Wu, M., Song, A., Dhang, F. H., Wei, Z., Costamagna, G., et al. (2019) · Cell Host & Microbe · doi:10.1016/j.chom.2019.10.008 · Cited by 198
Self-citationTakewaki, D., Suda, W., Sato, W., Takayasu, L., Kumar, N., Kimura, K., Kaga, N., Mizuno, T., Miyake, S., Hattori, M., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2011703117 · Cited by 188
Brain atrophy in multiple sclerosis: mechanisms, clinical relevance and treatment options
Andravizou, A., Dardiotis, E., Artemiadis, A., Sokratous, M., Siokas, V., Tsouris, Z., Aloizou, A., Nikolaidis, I., Bakirtzis, C., Tsivgoulis, G. K., et al. (2019) · Autoimmunity Highlights · doi:10.1186/s13317-019-0117-5 · Cited by 170
The multiple sclerosis gut microbiota: A systematic review
Mirza, A., Forbes, J. D., Zhu, F., Bernstein, C. N., Domselaar, G. V., Graham, M., Waubant, E. L., & Tremlett, H. L. (2019) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2019.101427 · Cited by 165
Glanz, B. I., Dégano, I. R., Rintell, D. J., Chitnis, T., Weiner, H. L., & Healy, B. C. (2012) · Value in Health · doi:10.1016/j.jval.2012.07.010 · Cited by 164
Self-citationRace and ethnicity on MS presentation and disease course
Amezcua, L., & McCauley, J. L. (2020) · Multiple Sclerosis Journal · doi:10.1177/1352458519887328 · Cited by 146
Taras, D., Simmering, R., Collins, M. D., Lawson, P. A., & Blaut, M. (2002) · INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY · doi:10.1099/00207713-52-2-423 · Cited by 143
Gut microbiome variation is associated to Multiple Sclerosis phenotypic subtypes
Reynders, T., Devolder, L., Valles‐Colomer, M., Remoortel, A. V., Joossens, M., Keyser, J. D., Nagels, G., D'hooghe, M. B., & Raes, J. (2020) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51004 · Cited by 126
Glanz, B. I., Healy, B. C., Rintell, D. J., Jaffin, S. K., Bakshi, R., & Weiner, H. L. (2010) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.11.004 · Cited by 124
Self-citationSerum lactate as a novel potential biomarker in multiple sclerosis
Amorini, A. M., Nociti, V., Petzold, A., Gasperini, C., Quartuccio, M. E., Lazzarino, G., Pietro, V. D., Belli, A., Signoretti, S., Vagnozzi, R., et al. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.04.005 · Cited by 124
Disease-modifying therapies alter gut microbial composition in MS
Sand, I. K., Zhu, Y., Ntranos, A., Clemente, J. C., Cekanaviciute, E., Brandstadter, R., Crabtree‐Hartman, E., Singh, S., Bencosme, Y., Debelius, J. W., et al. (2018) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000517 · Cited by 122
Tremlett, H. L., Fadrosh, D. W., Faruqi, A. A., Hart, J., Roalstad, S., Graves, J., Spencer, C. M., Lynch, S. V., Zamvil, S. S., & Waubant, E. L. (2016) · BMC Neurology · doi:10.1186/s12883-016-0703-3 · Cited by 121
Gut microbiome of treatment-naïve MS patients of different ethnicities early in disease course
Ventura, R. E., Iizumi, T., Battaglia, T., Liu, M., Perez-Perez, G. I., Herbert, J., & Blaser, M. J. (2019) · Scientific Reports · doi:10.1038/s41598-019-52894-z · Cited by 114
Clostridium bolteae sp. nov., Isolated from Human Sources
Song, Y., Liu, C., Molitoris, D. R., Tomzynski, T. J., Lawson, P. A., Collins, M. D., & Finegold, S. M. (2003) · Systematic and Applied Microbiology · doi:10.1078/072320203322337353 · Cited by 112
Cox, L. M., Sohn, J., Tyrrell, K. L., Citron, D. M., Lawson, P. A., Patel, N. B., Iizumi, T., Perez-Perez, G. I., Goldstein, E. J. C., & Blaser, M. J. (2017) · INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY · doi:10.1099/ijsem.0.001793 · Cited by 110
Self-citationHolland, C. M., Charil, A., Csapo, I., Liptak, Z., Ichise, M., Khoury, S. J., Bakshi, R., Weiner, H. L., & Guttmann, C. R. G. (2011) · Journal of Neuroimaging · doi:10.1111/j.1552-6569.2011.00585.x · Cited by 100
Self-citationColpitts, S. L., Kasper, E. J., Keever, A., Liljenberg, C., Kirby, T. O., Mágori, K., Kasper, L. H., & Ochoa‐Repáraz, J. (2017) · Gut Microbes · doi:10.1080/19490976.2017.1353843 · Cited by 97
Luise, D., Correa, F., Bosi, P., & Trevisi, P. (2020) · Animals · doi:10.3390/ani10050887 · Cited by 90
The Role of Gamma-Delta T Cells in Diseases of the Central Nervous System
Wo, J., Zhang, F., Li, Z., Sun, C., Zhang, W.-C., & Sun, G. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.580304 · Cited by 89
Cerebrospinal fluid lactate is associated with multiple sclerosis disease progression
Albanese, M., Zagaglia, S., Landi, D., Boffa, L., Nicoletti, C. G., Marciani, M. G., Mandolesi, G., Marfia, G. A., Buttari, F., Mori, F., et al. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0502-1 · Cited by 88
Kozhieva, M. K., Naumova, N., Alikina, T. Y., Boyко, A., Vlassov, V. V., & Kabilov, M. R. (2019) · BMC Microbiology · doi:10.1186/s12866-019-1685-2 · Cited by 75
Shkoporov, A. N., Chaplin, A. V., Shcherbakova, V. A., Сузина, Н. Е., Kafarskaia, L. I., Bozhenko, K. V., & Efimov, B. A. (2016) · INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY · doi:10.1099/ijsem.0.001143 · Cited by 68
Gut dysbiosis and multiple sclerosis
Noto, D., & Miyake, S. (2020) · Clinical Immunology · doi:10.1016/j.clim.2020.108380 · Cited by 65
Ahn, S., Jin, T.-E., Chang, D., Rhee, M.-S., Kim, H. J., Lee, S. J., Park, D., & Kim, B. C. (2016) · INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY · doi:10.1099/ijsem.0.001195 · Cited by 64
Chu, R., Tauhid, S., Glanz, B. I., Healy, B. C., Kim, G., Oommen, V. V., Khalid, F., Neema, M., & Bakshi, R. (2015) · Journal of Neuroimaging · doi:10.1111/jon.12271 · Cited by 56
Self-citationLiu, C., Huang, S., Wu, Z., Li, T., Li, N., Zhang, B., Han, D., Wang, S., Zhao, J., & Wang, J. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1903826 · Cited by 56
Pandit, L., Cox, L. M., Malli, C., D’Cunha, A., Rooney, T., Lokhande, H. A., Willocq, V., Saxena, S., & Chitnis, T. (2020) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000907 · Cited by 51
Self-citationRen, C., Wang, Y., Lin, X., Song, H., Zhou, Q., Xu, W., Shi, K., Chen, J., Song, J., Chen, F., et al. (2020) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.0c01414 · Cited by 50
Volkova, A., & Ruggles, K. V. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.621310 · Cited by 47
Pathogenicity Islands and Other Mobile Genetic Elements of Diarrheagenic Escherichia coli
Kaper, J. B., Mellies, J. L., & Nataro, J. P. (2014) · ASM Press eBooks · doi:10.1128/9781555818173.ch3 · Cited by 44
Dual‐Sensitivity Multiple Sclerosis Lesion and CSF Segmentation for Multichannel 3T Brain MRI
Meier, D., Guttmann, C. R. G., Tummala, S., Moscufo, N., Cavallari, M., Tauhid, S., Bakshi, R., & Weiner, H. L. (2017) · Journal of Neuroimaging · doi:10.1111/jon.12491 · Cited by 44
Self-citationChu, R., Hurwitz, S., Tauhid, S., & Bakshi, R. (2017) · BMC Neurology · doi:10.1186/s12883-017-0949-4 · Cited by 35
Self-citationMiller, D. H., LUBLIN, F. D., Sormani, M. P., Kappos, L., Yaldizli, Ö., Freedman, M. S., Cree, B., Weiner, H. L., Lubetzki, C., Hartung, H., et al. (2018) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.534 · Cited by 26
Self-citationEsmael, A., Talaat, M., Egilla, H., & Eltoukhy, K. (2021) · Neurological Research · doi:10.1080/01616412.2021.1893567 · Cited by 20
Seo, B., Jeon, K., Baek, I., Lee, Y. M., Baek, K., & Ko, G. (2019) · INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY · doi:10.1099/ijsem.0.003443 · Cited by 19
Cited by
Zhao, Z., Ning, J., Bao, X.-Q., Shang, M., Ma, J., Li, G., & Zhang, D. (2021) · Microbiome · doi:10.1186/s40168-021-01107-9 · Cited by 616
Jakimovski, D., Bittner, S., Zivadinov, R., Morrow, S. A., Benedict, R. H., Zipp, F., & Weinstock-Guttman, B. (2024) · The Lancet · doi:10.1016/s0140-6736(23)01473-3 · Cited by 597
Mou, Y., Du, Y., Zhou, L., Yue, J., Hu, X., Liu, Y., Chen, S., Lin, X., Zhang, G., Xiao, H., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.796288 · Cited by 432
Zhou, X., Baumann, R., Gao, X., Mendoza, M., Singh, S., Katz Sand, I., Xia, Z., Cox, L. M., Chitnis, T., Yoon, H., et al. (2022) · Cell · doi:10.1016/j.cell.2022.08.021 · Cited by 319
Self-citationGraves, J. S., Krysko, K. M., Hua, L. H., Absinta, M., Franklin, R. J. M., & Segal, B. M. (2023) · The Lancet Neurology · doi:10.1016/s1474-4422(22)00184-3 · Cited by 260
Metadata
- Authors
- Cox, L. M., Maghzi, A. H., Liu, S., Tankou, S. K., Dhang, F. H., Willocq, V., Song, A., Wasén, C., Tauhid, S., Chu, R., Anderson, M. C., De Jager, P. L., Polgar‐Turcsanyi, M., Healy, B. C., Glanz, B. I., Bakshi, R., Chitnis, T., & Weiner, H. L.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2021-04-30
- Volume
- 89
- Issue
- 6
- Pages
- 1195-1211
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W3156129427
- Cited by
- 293
- References
- 81
- FWCI
- 12.55
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.